Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company is headquartered in Bothell, Washington and currently employs 8 full-time employees. The company went IPO on 2000-07-25. The firm is in the preclinical stage of development and intends to file for orphan drug designation prior to entering the clinical development pathway. Its legacy business consists of an proprietary library of patented bioactive peptides. Its lead drug development candidate, HB4208, is a polypeptide DNA deoxyribonucleic (DNA) damage response (DDR) enzyme for topical treatment of the rare genetic disorder (orphan disease) XP. Its intellectual property portfolio offers multiple pathways for commercialization in this area ranging from Rx dermatology to aesthetic dermatology and personal care. The company is developing new treatment options for dermatologic conditions which offer the therapeutic effectiveness and safety benefits of its advanced bioactive small molecule technology. The company is also engaged in the treatment of skin conditions.
HXBM stock price ended at $1.75 on Vendredi, after dropping 12.50%
On the latest trading day Jan 23, 2026, the stock price of HXBM fell by 12.50%, dropping from $1.75 to $1.75. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $1.75 and a high of $1.75. On the latest trading day, the trading volume for HXBM rose by 40 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 140 shares were traded, with a market value of approximately $402.5K.
Signaux Techniques de HXBM
Résumé des Signaux Techniques
Acheter des signaux 3
Signaux neutres 2
Signaux de vente 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
HXBM présente actuellement 3 signaux d'achat et 2 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -12.5% pendant cette période. En général, les indicateurs techniques indiquent une tendance Buy à moyen terme.
Signaux haussiers/baissiers pour HXBM
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour HXBM, vous aidant à prendre des décisions d'investissement éclairées.
Questions complémentaires
Comment les indicateurs d'analyse technique s'appliquent-ils à HXBM ?
Quels sont les niveaux de retracement de Fibonacci pour HXBM ?
Quel est le RSI de Helix BioMedix Inc ?
Quel est le prix de Helix BioMedix Inc pour les 12 prochains mois ?